Skip to main content

Table 2 Proportion of individuals reaching LDL-C target

From: Lifetime risk assessment in cholesterol management among hypertensive patients: observational cross-sectional study based on electronic health record data

 

Age 30–49

Age 50–59

Age 60–69

Age 70–79

Age 80 -

Total

LDL-C TARGET REACHED

Women without LLM

  Yes, n (%)

119 (50.4)

132 (37.5)

250 (41.5)

235 (47.2)

192 (55.7)

928 (45.6)

Women with LLM

   Yes, n (%)

15 (55.6)

75 (48.1)

436 (62.1)

595 (70.0)

383 (66.6)

1504 (65.1)

Men without LLM

   Yes, n (%)

80 (41.2)

100 (36.8)

207 (46.1)

175 (54.4)

90 (66.2)

652 (47.5)

Men with LLM

   Yes, n (%)

27 (42.9)

90 (54.9)

362 (68.2)

337 (71.6)

121 (70.8)

937 (66.9)

LIPID-LOWERING MEDICATION

Women

  Yes, n (%)

27 (10.3)

156 (30.7)

702 (53.8)

850 (63.0)

575 (62.5)

2310 (53.2)

 Men

  Yes, n (%)

63 (24.5)

164 (37.6)

531 (54.2)

471 (59.4)

171 (55.7)

1400 (50.5)

  1. Abbreviations. LDL-C low-density lipoprotein, LLM lipid-lowering medication